Healthcare & Life Sciences
VedaCorp advised NU Hospitals, a leading nephrology and urology specialty hospital chain, on its Series A fundraise from Somerset Indus Capital Partners
About
NU Hospitals
NU Hospitals, incorporated in 1999 and headquartered in Bengaluru, is a leading provider of Nephrology and Urology services. NU Hospitals currently operates hospitals in Bengaluru (2), Shivamogga (1) Ambur (1) and Male, Maldives (1). NU Hospital addresses the rising burden of chronic kidney diseases through a scalable Centre of Excellence model, delivering ethical, affordable, and clinically governed care across nephrology, urology, fertility and renal transplant services. The platform is strengthened by its commitment to medical education and research, advanced robotics enabled surgical capabilities, and multiple quality accreditations including NABH, NABL, FEQH, and ISAR.
Somerset Indus Capital Partners
Somerset Indus Capital Partners (“Somerset”) is an impact-aligned private equity firm backing healthcare businesses to deliver quality, accessible, and affordable healthcare products and services across India’s underserved markets.
With deep expertise in healthcare and private equity, Somerset is guided by the theme of “Access to Affordable Quality Healthcare”, with a particular focus on underserved tier II and tier III geographies in India. Over the past decade, the firm has launched three funds, investing across hospitals, pharmaceuticals, diagnostics, medical technology, wellness, and healthcare financing.
Background
We are pleased to announce that our client, NU Hospitals Private Limited (“NU Hospitals”) has raised Series A funding from Somerset Indus Capital Partners (“Somerset”). The investment will support NU Hospitals’ next phase of growth, expand access to specialised nephrology and urology care in new markets and strengthen operational capabilities to serve a larger patient base in India as well as overseas.
NU Hospitals, incorporated in 1999 and headquartered in Bengaluru, is a leading provider of Nephrology and Urology services. NU Hospitals currently operates hospitals in Bengaluru (2), Shivamogga (1) Ambur (1) and Male, Maldives (1). All hospitals of the company in India are NABH accredited and it has a strong focus on clinical excellence, medical education and research.
Veda Corporate Advisors (“VedaCorp”) was the exclusive financial advisor to the NU Hospitals and its shareholders. VedaCorp provided comprehensive transaction advisory services covering identification of prospective investors, strategic positioning, deal structuring and negotiation of key commercial terms leading to the successful closure of the transaction.
This transaction marks VedaCorp’s 22nd deal in the rapidly evolving single specialty space and 64th transaction in healthcare and life sciences segment. The transaction reinforces VedaCorp’s track record in successfully advising mid-market investments in niche, single-specialty healthcare businesses.
“NU Hospitals is pleased to acknowledge the pivotal role played by Veda Corporate Advisors in this transaction. Veda’s sector expertise and strong execution capabilities were instrumental in efficiently closing the fundraise. Their deep understanding of the healthcare sector and investor landscape ensured a smooth, timely, and value-accretive process. NU Hospitals thanks Veda for its professionalism and strategic counsel throughout the transaction process”
Dr. Prasanna Venkatesh M K
Managing Director - NU Hospitals Private Limited
“Dr. Prasanna and team have built a differentiated platform in Nephrology and Urology services. NU is a clear market leader in these segments, underpinned by its strong focus on positive clinical outcomes, scalable operational model, and a clear growth vision. We are pleased to assist NU Hospitals on this transaction and believe this investment from Somerset will meaningfully accelerate the company’s expansion while preserving its patient-first culture”
Ganapathiraman
Managing Director and Mahesh Navada, Executive Director – VedaCorp